权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A chemical crosslinking strategy to determine DNA methylating protein complexes

确定 DNA 甲基化蛋白复合物的化学交联策略

基本信息

批准号：
7798219
负责人：
LUCY Ann GODLEY
金额：
$ 16.48万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-04-01 至 2011-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7798219
关键词：
Affect Aging BRCA1 gene Breast Cancer Cell CDH1 gene Cell Adhesion Cell physiology Cells Characteristics Chemicals Chemistry Chromatin Chromatin Structure Complex DNA DNA Methylation DNA Methyltransferase DNA Modification Methylases DNA Sequence Development Diagnosis E-Cadherin Embryonic Development Enzymes Epigenetic Process Estrogen Receptors Failure Future Gene Expression Genes Genetic Transcription Genomic Imprinting Glycoproteins Hematopoietic Neoplasms Hereditary Breast Carcinoma Histone Deacetylase Inhibitor Hormonal Human Hypermethylation Knowledge Laboratories Lead Malignant Neoplasms Mammary Neoplasms Mass Spectrum Analysis Mediating Methodology Methods Methylation Molecular Molecular Profiling Mutate Neoplasm Metastasis Normal Cell Normal tissue morphology Oligonucleotides Oncogenes Oncogenic Patients Pattern Phenotype Process Progesterone Receptors Proteins Proteomics Reaction Refractory Signal Transduction Solid Neoplasm Structure Techniques Therapeutic Tumor Suppressor Genes X Inactivation base cancer cell crosslink genome-wide hormone therapy human DNA link protein malignant breast neoplasm new technology novel novel diagnostics promoter protein complex research study tumor

项目摘要

DESCRIPTION (provided by applicant): Epigenetic changes alter chromatin structure, thereby regulating gene transcription. In normal cells, repetitive DNA is hypermethylated and transcriptionally silent, whereas transcribed gene promoters are undermethylated and associated with open chromatin. Cancer cells are characterized by abnormal DNA methylation: repetitive DNA sequences and some gene promoters are hypomethylated and transcriptionally active, whereas many tumor suppressor gene promoters are hypermethylated and transcriptionally inactive. Although many studies have focused on categorizing which genes have altered DNA methylation patterns in cancer cells, the precise components of the DNA methylation machinery mediating those changes have not been established. We propose to develop a unique method of chemical cross-linking and protein complex identification to identify the factors involved in promoter hypermethylation in breast cancer. Our new strategy is based on the development of novel chemical compounds synthesized within the He Laboratory and has significant advantages over other approaches in that it assembles a protein complex directly on a specific biologically relevant DNA. We envision applying this strategy to determine a quantitative molecular signature for DNA methylating complexes in cancer cells. To develop our new technology, we propose focusing on determining the protein complexes that mediate the hypermethylation of the promoters of BRCA1, a classic tumor suppressor gene, and CDH1, which encodes a protein important for cell adhesion, using two Specific Aims: (1) To incorporate novel chemical cross-linking compounds into oligonucleotides corresponding to the BRCA1 and CDH1 promoters, perform cross-linking to protein extracts from breast cancer cells, and identify the cross-linked proteins by mass spectroscopy; and (2) To compare the DNA methylating complexes quantitatively in human breast tumors versus normal tissue using our technique. In the future, a detailed understanding of the DNMT/other protein contacts at particular gene promoters could lead to the development of hypomethylating agents targeted to these promoters in a sequence-specific manner, thereby avoiding the consequences of genome-wide hypomethylation. In addition, the new chemistry allows formation of DNMT-DNA complexes at high efficiency, which could facilitate the structural characterization of human DNMT-DNA complexes.

描述（由申请人提供）：表观遗传变化改变染色质结构，从而调节基因转录。在正常细胞中，重复DNA高甲基化且转录沉默，而转录基因启动子低甲基化且与开放染色质相关。癌细胞的特征是异常的DNA甲基化：重复的DNA序列和一些基因启动子是低甲基化和转录活跃的，而许多肿瘤抑制基因启动子是高甲基化和转录不活跃的。尽管许多研究都集中在分类哪些基因改变了癌细胞中的DNA甲基化模式，但介导这些变化的DNA甲基化机制的精确组成部分尚未确定。